Clinical Trials · NCT07731256
Semaglutide for Low Back Pain
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Washington University School of Medicine
- Enrollment
- 250
- Start date
- Feb 2027
- Locations
- 2 sites, United States
- Primary endpoint
- BPI-SF Pain Severity Scale